Literature DB >> 30306220

Osteoporosis prevention: where are the barriers to improvement in a French general population? A qualitative study.

B Merle1, C Dupraz2, J Haesebaert3, L Barraud2, M Aussedat2, C Motteau2, V Simon2, A M Schott3, M Flori2,4.   

Abstract

We conducted a qualitative study with French men and women in order to provide insight into individuals' experiences, behaviors, and perceptions about osteoporosis (OP) and OP care. The data showed that both sexes, but especially men, were unfamiliar with OP, did not always feel concerned, and mistrusted pharmacological treatments.
INTRODUCTION: To engage actively in osteoporosis (OP) prevention, people need to have basic knowledge about the disease. The aim of this qualitative study was to explore knowledge and representations of OP care and prevention among both men and women.
METHODS: Focus groups were conducted in the Rhône-Alpes Region, France, with women aged 50-85 years and men aged 60-85 years, with or without a history of fragility fracture and/or an OP diagnosis (respectively referred to as "aware" or "unaware"). A total of 45 women (23 "aware" and 22 "unaware" in 5 and 4 focus groups, respectively) and 53 men (19 "aware" and 34 "unaware" in 3 and 4 focus groups, respectively) were included. A thematic analysis of transcripts was performed to explore knowledge and representations about OP, risk factors, prevention, and treatment.
RESULTS: The data showed that both sexes, but especially men, had limited knowledge of OP and considered it as a natural aging process not related to fragility fractures. They generally did not feel concerned by OP and no important difference was observed between "aware" and "unaware" patients. Women expressed their fear of the disease, associated with aging and the end of life, while men considered it to be a women's disease only. Both sexes were aware of OP risk factors, but were suspicious towards treatments because of the associated side effects.
CONCLUSION: Understanding people's representation of OP might help to provide patients with relevant information in order to optimize their preventive behavior and decrease the burden of the disease.

Entities:  

Keywords:  Focus groups; France; Men osteoporosis; Osteoporosis management; Qualitative research; Women osteoporosis

Mesh:

Substances:

Year:  2018        PMID: 30306220     DOI: 10.1007/s00198-018-4720-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  39 in total

1.  Osteoporosis treatment in postmenopausal women after peripheral fractures: impact of information to general practitioners.

Authors:  Sandrine Malochet-Guinamand; Nathalie Chalard; Claire Billault; Nadine Breuil; Jean-Michel Ristori; Jeannot Schmidt
Journal:  Joint Bone Spine       Date:  2005-03-19       Impact factor: 4.929

Review 2.  Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis.

Authors:  K Ganda; M Puech; J S Chen; R Speerin; J Bleasel; J R Center; J A Eisman; L March; M J Seibel
Journal:  Osteoporos Int       Date:  2012-07-25       Impact factor: 4.507

3.  Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.

Authors:  B Merle; R Chapurlat; E Vignot; T Thomas; J Haesebaert; A-M Schott
Journal:  Osteoporos Int       Date:  2017-02-28       Impact factor: 4.507

4.  Living with a `women's disease': risk appraisal and management among men with osteoporosis.

Authors:  Samantha L Solimeo
Journal:  J Mens Health       Date:  2011-10       Impact factor: 0.537

5.  2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis.

Authors:  Karine Briot; Bernard Cortet; Thierry Thomas; Maurice Audran; Hubert Blain; Véronique Breuil; Laure Chapuis; Roland Chapurlat; Patrice Fardellone; Jean-Marc Feron; Jean-Bernard Gauvain; Pascal Guggenbuhl; Sami Kolta; Eric Lespessailles; Brigitte Letombe; Christian Marcelli; Philippe Orcel; Patrick Seret; Florence Trémollières; Christian Roux
Journal:  Joint Bone Spine       Date:  2012-04-19       Impact factor: 4.929

6.  Association between bone turnover rate and bone microarchitecture in men: the STRAMBO study.

Authors:  Ali Chaitou; Stephanie Boutroy; Nicolas Vilayphiou; Françoise Munoz; Pierre D Delmas; Roland Chapurlat; Pawel Szulc
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

7.  Change in hip fracture incidence over the last 6 years in France.

Authors:  M Maravic; P Taupin; P Landais; C Roux
Journal:  Osteoporos Int       Date:  2010-06-02       Impact factor: 4.507

Review 8.  Older men's knowledge about osteoporosis and educational interventions to increase osteoporosis knowledge in older men: a systematic review.

Authors:  Jean M Gaines; Katherine A Marx
Journal:  Maturitas       Date:  2010-10-14       Impact factor: 4.342

9.  Osteoporosis screening for men: are family physicians following the guidelines?

Authors:  Natalie Cheng; Michael E Green
Journal:  Can Fam Physician       Date:  2008-08       Impact factor: 3.275

10.  Do patients perceive a link between a fragility fracture and osteoporosis?

Authors:  Lora Giangregorio; Alexandra Papaioannou; Lehana Thabane; Justin DeBeer; Ann Cranney; Lisa Dolovich; Anthony Adili; Jonathan D Adachi
Journal:  BMC Musculoskelet Disord       Date:  2008-03-21       Impact factor: 2.362

View more
  2 in total

1.  Adherence to Lifestyle Recommendations for Bone Health in Older Adults with and without Osteoporosis: Cross-Sectional Results of the OUTDOOR ACTIVE Study.

Authors:  Birte Marie Albrecht; Imke Stalling; Linda Foettinger; Carina Recke; Karin Bammann
Journal:  Nutrients       Date:  2022-06-14       Impact factor: 6.706

2.  Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis.

Authors:  Zoe Paskins; Fay Crawford-Manning; Elizabeth Cottrell; Nadia Corp; Jenny Wright; Clare Jinks; Simon Bishop; Alison Doyle; Terence Ong; Neil Gittoes; Jo Leonardi-Bee; Tessa Langley; Robert Horne; Opinder Sahota
Journal:  BMJ Open       Date:  2020-11-03       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.